Latest Investments News

Chorus Limited has reported a strong half-year performance driven by fibre broadband growth, operational efficiencies, and a return to profitability, while launching initiatives to boost digital inclusion.

Genesis Energy has reported a record first-half normalised EBITDAF of NZ$307 million, underpinned by strong hydro inflows and portfolio flexibility, while announcing a $400 million equity raise to accelerate its renewable growth strategy.

Cash Converters International Limited has announced the recommencement of its Dividend Reinvestment Plan (DRP) effective 20 February 2026, restoring shareholders’ ability to reinvest dividends into additional shares with favourable terms.

Forrestania Resources has contracted Como Engineers to deliver a fully automated modular gold processing plant for its Lake Johnston facility, marking a key step towards production. The $5.57 million plant will be pre-assembled and hot tested to streamline commissioning.

Cadence Opportunities Fund Limited has reported a remarkable turnaround for the half-year ending December 2025, posting a $6.4 million profit and raising its interim dividend to 7.5 cents per share.

Cadence Capital Limited has reported a remarkable turnaround with a 508% surge in profit after tax for the half-year ended December 2025, alongside a fully franked interim dividend declaration.

London City Equities Limited reported a 38% revenue increase and a $5.6 million capital gain from asset sales, while boosting liquidity to nearly 60% of its portfolio and raising dividends amid a cautious investment outlook.

Imperial Pacific Limited reported a half-year net profit of $148,000 for the six months ending December 2025, supported by strong asset growth and a fully franked 7 cent dividend. The company’s portfolio, including stakes in London City Equities and Excelsior Capital, drove net asset value to record highs despite a dip in profit.

PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.

Rural Funds Group has reported a striking 292% surge in profit after tax for the half year ending December 2025, alongside a 13% rise in revenue, signalling robust growth in its agricultural property portfolio.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.

Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.